Maria Kristina Andersson

Title: Maria Kristina Andersson: Innovator in Cardiovascular Diagnostics

Introduction

Maria Kristina Andersson is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of cardiovascular diagnostics, holding 2 patents that focus on innovative methods for detecting heart failure and assessing cardiovascular status.

Latest Patents

Her latest patents include "Reagents and methods for detection of heart failure," which provides novel reagents, kits, and methods for diagnosing predisposition to left ventricular heart failure. This invention is based on the analysis of polymorphic variants of genomic nucleic acid. Another significant patent is "Methods for assessing cardiovascular status and compositions for use thereof," which offers methods for evaluating cardiovascular status by determining the sequence at polymorphic positions within human genes encoding angiotensin converting enzyme (ACE), angiotensinogen (AGT), and type 1 angiotensin II receptor (AT1). This invention also includes isolated nucleic acids, nucleic acid probes, kits for predicting cardiovascular status, and targets for identifying candidate cardiovascular drugs.

Career Highlights

Throughout her career, Maria has worked with notable companies such as Pyrosequencing AB and Sequenom-Gemini Limited. Her work has significantly advanced the understanding and diagnosis of cardiovascular conditions.

Collaborations

Maria has collaborated with esteemed colleagues, including Leif Torbjörn Norberg and Per Harry Rutger Lindström, contributing to the advancement of cardiovascular research and diagnostics.

Conclusion

Maria Kristina Andersson is a trailblazer in the field of cardiovascular diagnostics, with her innovative patents paving the way for improved detection and assessment methods. Her contributions continue to impact the medical community positively.